Ackman says Valeant stock 'extraordinary bargain'
(Reuters) - Activist investor Bill Ackman said Valeant Pharmaceuticals International Inc's (NYSE: VRX) (NYSE: VRX) stock was an "extraordinary bargain" given its low price.
More doctors could use specialty pharmacies, potentially benefiting Valeant, and the selloff in the stock was unwarranted, Ackman said on Pershing Square's quarterly call on Monday.
He also said he had constructive meeting with the management of Mondelez International Inc (NASDAQ: MDLZ), in which he took a stake in August.
(Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Sriraj Kalluvila)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) Shorts Receive Warning From Elon Musk
- Mondelez International (MDLZ) PT Raised to $68 at UBS
- Tigress Financial Partners Starts Pershing Square Inc (PS) at Neutral
Create E-mail Alert Related Categories
Hedge Funds, Insiders' Blog, Reuters, Short SalesRelated Entities
William Ackman, Pershing Square CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share